New clot drug for heart patients
Hundreds of thousands of heart patients could benefit from new blood thinning drugs to cut their risk of stroke, guidelines recommend (Source: BBC News | Health | UK Edition)

Drug Target Identified For Diabetes
New research from the University of Cincinnati (UC) points to the naturally produced protein apolipoprotein A-IV (apoA-IV) as a potential target for a new diabetes therapeutic. Patrick Tso, PhD, professor in the UC Department of Pathology and Laboratory Medicine, has published research on the ability of apoA-IV to reduce blood sugar levels and enhance insulin secretion. The results appear the week of May 21, 2012, in the online early edition of Proceedings of the National Academy of Sciences. ApoA-IV is secreted by the small intestine in response to fat absorption... (Source: Health News from Medical News Today)